SPRY4 and cancer: SPRY4 was also suggested to be a downstream target of the non-canonical WNT (Wingless-related integration site) signaling pathway, inhibiting cancer cell growth, migration, and invasion in non-small-cell lung cancer (NSCLC) [48].